Spesolimab, an Anti-Interleukin-36 Receptor Antibody, in Patients with Palmoplantar Pustulosis: Results of a Phase IIa, Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Study

INTRODUCTION: Palmoplantar pustulosis (PPP) is a chronic, inflammatory skin disease, with high disease burden, that is often refractory to treatment. There is a high unmet clinical need for the treatment of patients with PPP. The objectives of this study were to evaluate the safety and efficacy of s...

Descripción completa

Detalles Bibliográficos
Autores principales: Mrowietz, Ulrich, Burden, A. David, Pinter, Andreas, Reich, Kristian, Schäkel, Knut, Baum, Patrick, Datsenko, Yakov, Deng, Hongjie, Padula, Steven J., Thoma, Christian, Bissonnette, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019016/
https://www.ncbi.nlm.nih.gov/pubmed/33661508
http://dx.doi.org/10.1007/s13555-021-00504-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019016/
https://www.ncbi.nlm.nih.gov/pubmed/33661508
http://dx.doi.org/10.1007/s13555-021-00504-0

Ejemplares similares